Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2025-12-24 @ 7:41 PM
NCT ID:
NCT06856603
Eligibility Criteria:
Inclusion Criteria:
* ECOG status 0-3
* Persistent or progressive cancer disease with 6 to 10 metastases
* ≤ 5 metastases in one organ
* Life expectancy \> 6 months for intracranial lesions
* Inability to surgically resect all metastatic lesions
* Positive tumor board decision for trial inclusion
* Signed informed consent
Exclusion Criteria:
* ECOG status 4
* De novo metastatic disease
* Radiological complete response after drug therapy
* Brain metastasis only
* Brain metastasis \> 3 cm, requiring neurosurgery
* Size of any metastasis \> 5 cm
* Previous radiation therapy for any metastatic site
* Leptomeningeal, pleural, or peritoneal carcinomatosis
* Spinal cord compression, requiring neurosurgery
* Invasion of great vessels, skin, or GI tract
* Negative tumor board decision for trial inclusion
* Unsigned informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06856603
Study Brief:
Protocol Section:
NCT06856603